Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Change in Cash (2020 - 2025)

Historic Change in Cash for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to $9.3 million.

  • Bioventus' Change in Cash fell 1648.01% to $9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$910000.0, marking a year-over-year decrease of 10560.1%. This contributed to the annual value of $4.6 million for FY2024, which is 992.78% down from last year.
  • As of Q3 2025, Bioventus' Change in Cash stood at $9.3 million, which was down 1648.01% from $10.1 million recorded in Q2 2025.
  • Bioventus' Change in Cash's 5-year high stood at $42.6 million during Q2 2021, with a 5-year trough of -$41.7 million in Q3 2022.
  • For the 5-year period, Bioventus' Change in Cash averaged around -$2.4 million, with its median value being -$2.5 million (2022).
  • Per our database at Business Quant, Bioventus' Change in Cash crashed by 58355.0% in 2022 and then surged by 53247.46% in 2024.
  • Quarter analysis of 5 years shows Bioventus' Change in Cash stood at -$31.7 million in 2021, then surged by 91.97% to -$2.5 million in 2022, then surged by 498.31% to $10.1 million in 2023, then plummeted by 114.72% to -$1.5 million in 2024, then surged by 720.24% to $9.3 million in 2025.
  • Its Change in Cash stands at $9.3 million for Q3 2025, versus $10.1 million for Q2 2025 and -$18.8 million for Q1 2025.